ANI Pharmaceuticals, Inc. (ANIP) Balance Sheet
ANIP balance sheet, 2025
December 31, 2025 · U.S. dollars$1.44B assets = $899.7M liabilities + $540.7M equity
Both columns are drawn to the same scale: what ANIP owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ANIP financial health
Descriptive bands, not a rating. Fiscal 2025.
ANIP balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $322.9M2016 | $1.44B2025 | +18.1%/yr | |
| Total liabilities | $153.2M2016 | $899.7M2025 | +21.7%/yr | |
| Shareholders’ equity | $169.6M2016 | $540.7M2025 | +13.7%/yr | |
| Cash & short-term investments | $27.4M2016 | $285.6M2025 | +29.8%/yr | |
| Total debt | $120.6M2016 | $325.2M2025 | +11.6%/yr | |
| Net cash (debt) | −$93.3M2016 | −$39.6M2025 | +$53.7M | |
| Working capital | $71.1M2016 | $475.0M2025 | +$403.9M | |
| Book value per share | $14.662016 | $25.472025 | +6.3%/yr | |
| Current ratio | 3.222016 | 2.712025 | −0.52 | |
| Debt / equity | 0.712016 | 0.602025 | −0.11 | |
| Shares outstanding | 11.6M2016 | 21.2M2025 | +7.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ANIP assets
ANIP liabilities and equity
ANIP debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ANIP balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $285.6M | $151.2M | $221.1M | $48.2M | $100.3M | $7.9M | $62.3M | $43.0M | $31.1M | $27.4M |
| Cash & equivalents | $285.6M | $144.9M | $221.1M | $48.2M | $100.3M | $7.9M | $62.3M | $43.0M | $31.1M | $27.4M |
| Short-term investments | $9.1M | $6.3M | $0 | — | — | — | — | — | $0 | $0 |
| Receivables | $281.1M | $221.7M | $162.1M | $165.4M | $128.5M | $95.8M | $72.1M | $64.8M | $58.8M | $45.9M |
| Inventory | $143.1M | $136.8M | $111.2M | $105.4M | $81.7M | $60.8M | $48.2M | $40.5M | $37.7M | $26.2M |
| Other current assets | $43.4M | $18.0M | $25.4M | $25.2M | $11.3M | $5.9M | $5.1M | $4.5M | $3.9M | $3.6M |
| Total current assets | $753.1M | $527.7M | $519.8M | $344.3M | $321.8M | $170.3M | $187.7M | $152.9M | $131.6M | $103.0M |
| Property, plant & equipment (net) | $62.5M | $56.9M | $44.6M | $43.2M | $52.7M | $41.3M | $40.6M | $38.1M | $20.4M | $11.0M |
| Goodwill & intangible assets | $542.0M | $601.8M | $237.2M | $279.9M | $322.0M | $192.1M | $184.0M | $205.2M | $231.6M | $177.6M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $82.8M | $97.3M | $102.8M | $92.7M | $75.1M | $57.5M | $44.6M | $34.5M | $28.5M | $31.2M |
| Total assets | $1.44B | $1.28B | $904.4M | $760.1M | $771.6M | $461.2M | $456.8M | $430.6M | $412.1M | $322.9M |
| Liabilities | ||||||||||
| Accounts payable | $62.6M | $45.7M | $36.7M | $29.3M | $23.0M | $11.3M | $14.6M | $8.9M | $3.6M | $3.4M |
| Short-term debt | $17.3M | $9.2M | $850,000 | $850,000 | $850,000 | $13.2M | $9.9M | $115.7M | $3.4M | $120.6M |
| Deferred revenue | — | — | $32.5M | — | $87,000 | $80,000 | $451,000 | $711,000 | $24.0M | — |
| Total current liabilities | $278.1M | $193.7M | $145.5M | $99.4M | $87.5M | $78.6M | $61.7M | $165.5M | $39.2M | $31.9M |
| Long-term debt | $599.8M | $614.9M | $284.8M | $285.7M | $286.5M | $172.4M | $175.8M | $67.3M | $128.2M | $120.6M |
| Other long-term liabilities | $21.8M | $46.6M | $16.5M | $36.4M | $38.8M | $14.5M | $6.5M | $496,000 | $69.9M | $625,000 |
| Total liabilities | $899.7M | $855.2M | $446.8M | $421.5M | $412.9M | $265.5M | $244.0M | $233.3M | $237.4M | $153.2M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $3,000 | $2,000 | $2,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$23.1M | −$100.3M | −$80.1M | −$97.3M | −$47.8M | −$5.0M | $17.6M | $11.5M | −$4.0M | −$2.9M |
| Treasury stock | — | — | — | — | — | — | −$723,000 | −$659,000 | −$259,000 | $0 |
| Accumulated other comprehensive income | $1.0M | $5.3M | $8.9M | $12.2M | −$3.1M | −$11.4M | −$4.9M | −$379,000 | −$6.6M | −$5.4M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $540.7M | $428.5M | $457.6M | $338.5M | $358.7M | $195.7M | $212.8M | $197.3M | $174.8M | $169.6M |
| Key figures | ||||||||||
| Total debt | $325.2M | $624.1M | $285.7M | $286.5M | $287.4M | $185.7M | $185.7M | $183.0M | $201.5M | $120.6M |
| Net cash (debt) | −$39.6M | −$472.9M | −$64.5M | −$238.3M | −$187.1M | −$177.8M | −$123.4M | −$140.0M | −$170.4M | −$93.3M |
| Working capital | $475.0M | $334.0M | $374.3M | $244.8M | $234.2M | $91.8M | $126.0M | −$12.7M | $92.4M | $71.1M |
| Tangible book value | −$1.3M | −$173.3M | $220.4M | $58.7M | $36.7M | $3.6M | $28.8M | −$7.9M | −$56.9M | −$8.0M |
| Book value per share | $25.47 | $22.18 | $25.15 | $20.82 | $28.48 | $16.36 | $17.67 | $16.76 | $15.13 | $14.66 |
| Shares outstanding | 21.2M | 19.3M | 18.2M | 16.3M | 12.6M | 12.0M | 12.0M | 11.8M | 11.5M | 11.6M |
| Current ratio | 2.71 | 2.72 | 3.57 | 3.46 | 3.68 | 2.17 | 3.04 | 0.92 | 3.35 | 3.22 |
| Quick ratio | 2.04 | 1.93 | 2.63 | 2.15 | 2.61 | 1.32 | 2.18 | 0.65 | 2.29 | 2.29 |
| Debt / equity | 0.60 | 1.46 | 0.62 | 0.85 | 0.80 | 0.95 | 0.87 | 0.93 | 1.15 | 0.71 |
| Equity / assets | 37.5% | 33.4% | 50.6% | 44.5% | 46.5% | 42.4% | 46.6% | 45.8% | 42.4% | 52.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $375.9M | $311.2M | $285.6M | $262.6M | $223.5M | $155.2M | $151.2M | $153.3M | $247.1M | $238.3M | $221.1M | $193.1M |
| Cash & equivalents | $360.2M | $311.2M | $285.6M | $262.6M | $217.8M | $149.8M | $144.9M | $145.0M | $240.1M | $228.6M | $221.1M | $193.1M |
| Short-term investments | $15.6M | $14.9M | $9.1M | $8.9M | $5.7M | $5.4M | $6.3M | $8.3M | $6.9M | $9.7M | — | — |
| Receivables | $274.5M | $255.4M | $281.1M | $252.6M | $225.7M | $220.3M | $221.7M | $196.4M | $166.1M | $172.4M | $162.1M | $178.8M |
| Inventory | $143.1M | $143.5M | $143.1M | $146.5M | $138.3M | $137.4M | $136.8M | $148.0M | $125.4M | $113.8M | $111.2M | $106.6M |
| Other current assets | $31.9M | $37.0M | $43.4M | $36.7M | $15.1M | $23.4M | $18.0M | $23.6M | $16.9M | $16.1M | $25.2M | $18.7M |
| Total current assets | $825.4M | $747.1M | $753.1M | $698.4M | $602.6M | $536.3M | $527.7M | $521.3M | $555.5M | $540.6M | $519.6M | $497.2M |
| Property, plant & equipment (net) | $73.2M | $67.1M | $62.5M | $63.6M | $59.2M | $58.2M | $56.9M | $56.7M | $51.6M | $48.5M | $44.6M | $44.2M |
| Goodwill & intangible assets | $512.3M | $529.6M | $542.0M | $562.3M | $580.9M | $599.2M | $601.8M | $630.3M | $211.3M | $224.3M | $237.2M | $248.0M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $83.1M | $78.1M | $82.8M | $83.9M | $100.3M | $98.8M | $97.3M | $79.1M | $102.4M | $101.2M | $103.0M | $100.5M |
| Total assets | $1.49B | $1.42B | $1.44B | $1.41B | $1.34B | $1.29B | $1.28B | $1.29B | $920.8M | $914.5M | $904.4M | $889.9M |
| Liabilities | ||||||||||||
| Accounts payable | $73.8M | $69.7M | $62.6M | $69.8M | $54.6M | $53.1M | $45.7M | $60.9M | $48.7M | $49.4M | $36.7M | $34.1M |
| Short-term debt | $21.3M | $19.3M | $17.3M | $15.2M | $13.2M | $11.2M | $9.2M | $7.2M | $850,000 | $850,000 | $850,000 | $850,000 |
| Deferred revenue | — | — | — | — | — | — | — | $6.1M | $2.9M | $11.4M | $8.2M | $75.5M |
| Total current liabilities | $283.7M | $239.5M | $278.1M | $270.6M | $236.8M | $201.8M | $193.7M | $189.9M | $140.0M | $136.9M | $145.5M | $134.4M |
| Long-term debt | $589.2M | $594.5M | $599.8M | $605.1M | $608.3M | $611.6M | $614.9M | $618.2M | $284.4M | $284.6M | $284.8M | $285.0M |
| Other long-term liabilities | $24.1M | $25.7M | $21.8M | $26.7M | $36.2M | $35.5M | $46.6M | $48.4M | $15.8M | $41.1M | $41.4M | $15.8M |
| Total liabilities | $896.9M | $859.7M | $899.7M | $902.3M | $881.4M | $849.0M | $855.2M | $856.6M | $440.1M | $462.6M | $471.7M | $435.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Retained earnings (deficit) | $31.1M | $6.4M | −$23.1M | −$50.6M | −$76.9M | −$85.0M | −$100.3M | −$89.6M | −$65.0M | −$62.3M | −$80.1M | −$80.9M |
| Accumulated other comprehensive income | −$327,000 | $478,999 | $1.0M | $2.8M | $3.3M | $3.6M | $5.3M | $5.4M | $8.3M | $9.4M | $8.9M | $14.1M |
| Total shareholders' equity | $597.2M | $562.3M | $540.7M | $505.8M | $461.6M | $443.5M | $428.5M | $430.8M | $480.6M | $452.0M | $432.7M | $454.7M |
| Key figures | ||||||||||||
| Total debt | $330.3M | $327.8M | $325.2M | $322.6M | $621.6M | $622.8M | $624.1M | $625.4M | $285.2M | $310.3M | $315.3M | $285.9M |
| Net cash (debt) | $45.5M | −$16.6M | −$39.6M | −$60.0M | −$398.0M | −$467.6M | −$472.9M | −$472.1M | −$38.2M | −$72.1M | −$94.2M | −$92.8M |
| Working capital | $541.8M | $507.6M | $475.0M | $427.8M | $365.8M | $334.5M | $334.0M | $331.4M | $415.5M | $403.7M | $374.1M | $362.9M |
| Tangible book value | $84.9M | $32.7M | −$1.3M | −$56.5M | −$119.2M | −$155.7M | −$173.3M | −$199.5M | $269.3M | $227.7M | $195.5M | $206.7M |
| Book value per share | $27.25 | $26.10 | $25.47 | $23.98 | $22.73 | $22.12 | $22.04 | $22.20 | $24.88 | $23.27 | $22.52 | $23.78 |
| Shares outstanding | 21.9M | 21.5M | 21.2M | 21.1M | 20.3M | 20.0M | 19.4M | 19.4M | 19.3M | 19.4M | 19.2M | 19.1M |
| Current ratio | 2.91 | 3.12 | 2.71 | 2.58 | 2.54 | 2.66 | 2.72 | 2.74 | 3.97 | 3.95 | 3.57 | 3.70 |
| Quick ratio | 2.29 | 2.37 | 2.04 | 1.90 | 1.90 | 1.86 | 1.93 | 1.84 | 2.95 | 3.00 | 2.63 | 2.77 |
| Debt / equity | 0.55 | 0.58 | 0.60 | 0.64 | 1.35 | 1.40 | 1.46 | 1.45 | 0.59 | 0.69 | 0.73 | 0.63 |
| Equity / assets | 40.0% | 39.5% | 37.5% | 35.9% | 34.4% | 34.3% | 33.4% | 33.5% | 52.2% | 49.4% | 47.8% | 51.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 27, 2026); data from EODHD.
ANIP financial position
At the end of fiscal 2025 (December 31, 2025), ANI Pharmaceuticals had total assets of $1.4 billion (up 12.2% from a year earlier), total liabilities of $899.7 million and shareholders' equity of $540.7 million. It held $285.6 million in cash and short-term investments against $325.2 million of debt, net debt of $39.6 million. Its current ratio was 2.71. In the latest quarter (ended June 30, 2026) total assets were $1.5 billion and equity $597.2 million.
Related: ANIP income statement, ANIP cash flow statement, ANIP key metrics. See the ANIP stock overview for the latest quote and news.
ANIP balance sheet FAQ
What are ANI Pharmaceuticals's total assets?
ANI Pharmaceuticals reported total assets of $1.4 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.3 billion a year earlier.
How much debt does ANI Pharmaceuticals have?
ANI Pharmaceuticals had $325.2 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.60.
How much cash does ANI Pharmaceuticals have?
ANI Pharmaceuticals held $285.6 million in cash and short-term investments at the end of fiscal 2025; with $325.2 million of debt that is net debt of $39.6 million.
What is ANI Pharmaceuticals's book value?
ANI Pharmaceuticals's shareholders' equity (book value) was $540.7 million at the end of fiscal 2025, or $25.47 per share.
What is ANI Pharmaceuticals's current ratio?
ANI Pharmaceuticals had current assets of $753.1 million and current liabilities of $278.1 million, a current ratio of 2.71 (it can cover its short-term obligations).
How much goodwill does ANI Pharmaceuticals have?
ANI Pharmaceuticals carried $542.0 million of goodwill and intangible assets, 37.6% of total assets, at the end of fiscal 2025.